These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 13659813)

  • 1. [New treatments for cancer of the prostate].
    AMIEL C
    Vie Med; 1959 Apr; 40(4):337 passim. PubMed ID: 13659813
    [No Abstract]   [Full Text] [Related]  

  • 2. [Indications and results of endoscopic resections in cancer of the prostate].
    Olănescu G; Stoianovici S; Cornea G
    Chirurgia (1951); 1972 Mar; 21(3):207-9. PubMed ID: 5070727
    [No Abstract]   [Full Text] [Related]  

  • 3. [Secondary cancer of the lung of prostatic origin; recovery maintained for 3 years by diethylstilbestrol therapy].
    MEYER A; LIOT F
    Bull Mem Soc Med Hop Paris; 1954 Mar 26-Apr 9; 70(11-12):401-4. PubMed ID: 13172629
    [No Abstract]   [Full Text] [Related]  

  • 4. Endocrine-control therapy in prostatic cancer.
    FERGUSSON JD
    Br J Urol; 1958 Dec; 30(4):397-406; discussion 411-4. PubMed ID: 13608018
    [No Abstract]   [Full Text] [Related]  

  • 5. Preliminary report of a controlled trial in advanced breast cancer comparing tamoxifen with conventional hormone therapy.
    Roberts HM; Forrest AP; Hamilton T; Langlands AO; Lutz W; McFadyen IJ; Stewart HJ
    Cancer Treat Rep; 1976 Oct; 60(10):1461-2. PubMed ID: 798627
    [No Abstract]   [Full Text] [Related]  

  • 6. [Results of conservative therapy in prostate carcinoma].
    PAGEL W
    Z Urol; 1957; 50(12):681-8. PubMed ID: 13531567
    [No Abstract]   [Full Text] [Related]  

  • 7. Planned cytostatic therapy of carcinoma of the prostate.
    WARNECKE CE
    Bruns Beitr Klin Chir; 1955 May; 190(3):341-8. PubMed ID: 14389781
    [No Abstract]   [Full Text] [Related]  

  • 8. [Metastatic prostate cancer. High-dose diethylstilbestrol and hormonal escape].
    Chaouat D; Court B
    Rev Rhum Ed Fr; 1994 Apr; 61(4):290. PubMed ID: 7920531
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cancer of the lung metastatic from the prostate; disappearance of the radiological images after diethylstilbestrol therapy].
    MEYER A; HINAUT G; LIOT F
    Bull Mem Soc Med Hop Paris; 1951 Oct 19-26; 67(27-28):1190-5. PubMed ID: 14925878
    [No Abstract]   [Full Text] [Related]  

  • 10. [Endocrine therapy of prostate cancer 1945-47].
    BOJSEN F
    Ugeskr Laeger; 1954 Jul; 116(27):1010-4. PubMed ID: 13196179
    [No Abstract]   [Full Text] [Related]  

  • 11. Estramustine phosphate vs diethylstilbestrol in the treatment of stage D prostate cancer.
    Benson RC; Cummings K
    Prog Clin Biol Res; 1989; 303():177-86. PubMed ID: 2674984
    [No Abstract]   [Full Text] [Related]  

  • 12. Prostatic cancer. III. Advantages of large oral dosage of diethylstilbestrol.
    FISH GW; HUDSON PB; JOST HM
    J Urol; 1954 Dec; 72(6):1222-3. PubMed ID: 13212944
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyproterone acetate versus medroxyprogesterone acetate versus diethylstilbestrol in the treatment of prostate cancer: results from EORTC Study 30761.
    Pavone-Macaluso M; Ingargiola GB; de Voogt H; Viggiano G; Barasolo E; Lardennois B; De Pauw M; Sylvester R
    Prog Clin Biol Res; 1987; 243A():379-82. PubMed ID: 2958862
    [No Abstract]   [Full Text] [Related]  

  • 14. Biologic titration of diethylstilbestrol against activity of prostatic cancer: effect on serum aldolase.
    BAKER R; GOVAN D; HUFFER J; CASON J
    J Clin Endocrinol Metab; 1953 Apr; 13(4):383-91. PubMed ID: 13052668
    [No Abstract]   [Full Text] [Related]  

  • 15. [New methods of treatment of prostatic carcinoma].
    HASCHE-KLUNDER R; GACA A
    Med Klin; 1955 Dec; 50(48):2032-5. PubMed ID: 13287784
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical study of diethylstilbestrol in hormone refractory prostate cancer].
    Wang JW; Zhou LQ; Ji SQ; Song G; Li XS; He ZS
    Zhonghua Yi Xue Za Zhi; 2011 Aug; 91(32):2247-9. PubMed ID: 22094088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapeutic aspects in the treatment of prostatic cancer.
    HASCHE-KLUNDER R; WILMANNS H
    Br J Urol; 1957 Mar; 29(1):20-4. PubMed ID: 13413208
    [No Abstract]   [Full Text] [Related]  

  • 18. [How should patients with prostate cancer be treated?].
    Hvidt V
    Ugeskr Laeger; 1977 Feb; 139(9):543-4. PubMed ID: 841747
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of cancer of prostate & its metastases by chlorotrianisene (TACE)].
    HERBEUVAL R; GUILLEMIN P; CUNY G; LARCAN A; BESSOT M
    J Urol Medicale Chir; 1957 Jun; 63(6):422-6. PubMed ID: 13476487
    [No Abstract]   [Full Text] [Related]  

  • 20. Deferred hormone treatment in prostate cancer.
    Hall RR
    Prog Clin Biol Res; 1987; 243B():439-40. PubMed ID: 3659037
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.